2014-04-18 12:49:04 - The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry - a new market research report on companiesandmarkets.com
We have been analyzing IVD markets for decades and brings its knowledge of the market to this new law. This report, examines the effects of the Patient Protection and Affordable Care Act´s provisions on IVD sales, procedure volumes and profits. Analyst Alison Sahoo calculates the effects of the legislation good and bad in a way that business planners can utilize.
The report examines the proposed positive developments for the IVD industry resulting from PPACA such as an expansion in the number of insured U.S. persons, increased utilization of tests related to nosocomial infections, product innovation resulting from value-based pricing, and new coverage of wellness and prevention programs. The report also examines legislation components that might present challenges, such as the medical
device excise tax and changes to Medicare reimbursement. Finally, the report looks at the unresolved questions of the legislation.
In the course of its analysis, the report provides the following:
- Complete Explanation Of The Legislation And Major Provisions
- Implementation Of Selected PPACA Provisions By Year
- Current Status Of PPACA Implementation
- U.S. IVD Procedure Volumes, 2012-2022
- U.S. Market For IVD And Clinical Lab Tests, 2012 â 2022
- Impact Of Expected Increase In Newly Insured Patients
- Likely New Sales Due To Nosocomial Infection Provisions
- New Sales From Device Innovation Demand Resulting From PPACA
- Estimated Loss Of Revenues From Taxes And Medicare Cuts
- Effect Of Wellness And Prevention Programs
- Recent IVD Consolidation
- The Role Of ACOS
- Impact Of The Medical Device Tax And Recent Developments
- State Expansion Of Medicaid
- IVD Capital Purchasing, Public Confusion And Other Trends.
In this report, sales estimates for the overall market represent U.S. revenues and are expressed in current dollars. Estimates are provided for the historic 2012 period and forecasts are provided through 2022. The report also presents overall procedure volumes for IVD and laboratory tests. It covers only commercialized tests, specifically excluding those that are developmental or used primarily for research purposes. Historical information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts´ reports and other sources.
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.